Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021)

Name: Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021) | Business Quant
Creator: Business Quant

Acro Biomedical's quarterly Share-based Compensation came in at $3.9 million in Q4 2021, up 34.59% quarter-over-quarter from $2.9 million in Q3 2021.

Acro Biomedical has reported Share-based Compensation for 3 years, with the latest figure at $3.9 million in Q4 2021.

For the quarter ending Q4 2021, Share-based Compensation changed N/A year-over-year to $3.9 million; the trailing twelve-month figure through Dec 2021 stood at $7.0 million (changed N/A YoY), and the FY2021 full-year result was $7.7 million, changed N/A from the prior year.
Share-based Compensation for Q4 2021 stood at $3.9 million, up from $2.9 million in the prior quarter.
The five-year high for Share-based Compensation was $3.9 million in Q4 2021, with the low at $148395.0 in Q1 2019.
Average Share-based Compensation over 3 years is $1.2 million, with a median of $150044.5 recorded in 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	EQV Ventures Acquisition	477.69 Mn	477.69 Mn	-	-
2	Berto Acquisition	316.66 Mn	316.66 Mn	-	-
3	Centurion Acquisition	311.94 Mn	311.94 Mn	-	-
4	Churchill Capital Corp IX	311.36 Mn	311.36 Mn	-	-
5	Agriculture & Natural Solutions Acquisition	301.94 Mn	301.94 Mn	-	-
6	Siddhi Acquisition Corp (Cayman Islands)	286.76 Mn	286.76 Mn	-	-
7	Bold Eagle Acquisition	276.06 Mn	276.06 Mn	-	-
8	Cartesian Growth Corp III	270.68 Mn	270.68 Mn	-	-
9	Oyster Enterprises II Acquisition	266.84 Mn	266.84 Mn	-	-
10	Acro Biomedical	-	-	-	-

Download Data 🔒